Fanconi anemia (FA), dyskeratosis congenita (DC), and Diamond Blackfan anemia (DBA)
are 3 of the most common inherited bone marrow failure syndromes (IBMFS), in which the …

Fanconi anemia (FA) is an inherited bone marrow failure syndrome characterized by
chromosomal fragility, progressive marrow failure, and cancer predisposition. Hematopoietic …

Purpose Allogeneic hematopoietic cell transplantation (HCT) can cure bone marrow failure
in patients with Fanconi anemia (FA). Data on outcomes in patients with pretransplantation …

Bone marrow failure syndrome is an epithet of bone marrow failure (all or single-cell
lineage) that is attributable to an underlying genetic aberration usually with a constellation of …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical
matched sibling (MSD) is one of the most successful therapies in patients with non …

Cells from Fanconi anemia (FA) patients are hypersensitive to alkylating agents and
radiation traditionally used as conditioning regimens for marrow cell transplantation, and …

Allogeneic hematopoietic cell transplantation (HCT) has been shown to restore normal
hematopoiesis in patients with Fanconi anemia (FA), with excellent results in matched …

Hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with
Fanconi Anemia (FA), and it is generally accepted that these patients should receive low …

Allogeneic haematopoietic cell transplantation (HCT) is effective therapy for Fanconi
anaemia (FA). FA patients do not tolerate conditioning with 200 mg/kg of cyclophosphamide …

Low-dose cyclophosphamide (CY) is now considered the backbone of many of the
conditioning regimens used in patients with Fanconi anemia undergoing allogeneic stem …